Gastric cardia carcinoma is associated with the promoter -77T>C gene polymorphism of X-Ray Cross-Complementing Group 1 (XRCC1)

Journal of Gastrointestinal Surgery

Volumn 13, Issue 12, 2009, Pages 2233-2238

  Corso, Giovanni ^a,b,c,e   Marrelli, Daniele ^a,c   Pedrazzani, Corrado ^a,c   Machado, José Carlos ^b,d   Mancini, Stefano ^a   Seruca, Raquel ^b,d   Roviello, Franco ^a,c  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF PORTO   (Portugal)

^c ISTITUTO TOSCANO TUMORI   (Italy)

^d University of Porto   (Portugal)

^e UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

Gastric cancer; Risk factor; Single nucleotide genetic polymorphism

Indexed keywords

ARTICLE; CARDIA; DNA REPAIR; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; LUNG TUMOR; MALE; MIDDLE AGED; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH TUMOR;

CARDIA; DNA REPAIR; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; STOMACH NEOPLASMS;

EID: 71149103691     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-009-0980-x     Document Type: Article

References (27)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. Bray F, Sankila R, Ferlay J, Parkin DM. Estimates of cancer incidence and mortality in Europe in 1995. Eur J Cancer 2002; 38: 99-166.
3. La Vecchia C, Lucchini F, Negri E, Boyle P, Maisonneuve P, Levi F. Trends of cancer mortality in Europe, 1955-1989: I, Digestive sites. Eur J Cancer 1992; 28: 132-235.
4. Canedo P, Corso G, Pereira F, Lunet N, Suriano G, Figueiredo C, Pedrazzani C, Moreira H, Barros H, Carneiro F, Seruca R, Roviello F, Machado JC. The interferon gamma receptor 1 (IFNGR1) -56C/T gene polymorphism is associated with increased risk of early gastric carcinoma. Gut 2008; 57: 1504-1508.
5. Canedo P, Figueiredo C, Machado JC. After Helicobacter pylori, genetic susceptibility to gastric carcinoma revisited. Helicobacter 2007; 12(Suppl 2): 45-49.
6. Marrelli D, Pedrazzani C, Berardi A, Corso G, Neri A, Garosi L, Vindigni C, Santucci A, Figura N, Roviello F. Negative Helicobacter pylori status is associated with poor prognosis in patients with gastric cancer. Cancer 2009; 115: 2071-2080.
7. Machado JC, Figueiredo C, Canedo P, Pharoah P, Carvalho R, Nabais S, Castro Alves C, Campos ML, van Doorn LJ, Caldas C, Seruca R, Carneiro F, Sobrinho-Simões M. A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma. Gastroenterology 2003; 125: 364-371.
8. Figueiredo C, Machado JC, Pharoah P, Seruca R, Sousa S, Carvalho R, Capelinha AF, Quint W, Caldas C, van Doorn LJ, Carneiro F, Sobrinho-Simões M. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst 2002; 94: 1680-1687.
9. Machado AM, Figueiredo C, Touati E, Máximo V, Sousa S, Michel V, Carneiro F, Nielsen FC, Seruca R, Rasmussen LJ. Helicobacter pylori infection induces genetic instability of nuclear and mitochondrial DNA in gastric cells. Clin Cancer Res 2009; 15: 2995-3002.
10. Wei Q, Cheng L, Hong WK, Spitz MR. Reduced DNA repair capacity in lung cancer patients. Cancer Res 1996; 56: 4103-4107.
11. Li WQ, Zhang L, Ma JL, Zhang Y, Li JY, Pan KF, You WC. Association between genetic polymorphisms of DNA base excision repair genes and evolution of precancerous gastric lesions in a Chinese population. Carcinogenesis 2009; 30: 500-505.
12. Hu Z, Ma H, Lu D, Zhou J, Chen Y, Xu L, Zhu J, Huo X, Qian J, Wei Q, Shen H. A promoter polymorphism (-77T> C) of DNA repair gene XRCC1 is associated with risk of lung cancer in relation to tobacco smoking. Pharmacogenet Genomics 2005; 15: 457-463.
13. Hao B, Miao X, Li Y, Zhang X, Sun T, Liang G, Zhao Y, Zhou Y, Wang H, Chen X, Zhang L, Tan W, Wei Q, Lin D, He F. A novel T-77C polymorphism in DNA repair gene XRCC1 contributes to diminished promoter activity and increased risk of non-small cell lung cancer. Oncogene 2006; 25: 3613-36120.
14. Roviello F, Corso G, Pedrazzani C, Marrelli D, De Falco G, Suriano G, Vindigni C, Berardi A, Garosi L, De Stefano A, Leoncini L, Seruca R, Pinto E. High incidence of familial gastric cancer in Tuscany, a region in Italy. Oncology 2007; 72: 243-247.
15. Pedrazzani C, Corso G, Velho S, Leite M, Pascale V, Bettarini F, Marrelli D, Seruca R, Roviello F. Evidence of tumor microsatellite instability in gastric cancer with familial aggregation. Fam Cancer 2009; 8: 215-220.
16. Brem R, Hall J. XRCC1 is required for DNA single-strand break repair in human cells. Nucleic Acids Res 2005; 33: 2512-2520.
17. Brem R, Cox DG, Chapot B, Moullan N, Romestaing P, Gérard JP, Pisani P, Hall J. The XRCC1 -77T-> C variant: haplotypes, breast cancer risk, response to radiotherapy and the cellular response to DNA damage. Carcinogenesis 2006; 27: 2469-2474.
18. Hsieh WC, Cheng YW, Lin CJ, Chou MC, Chen CY, Lee H. Prognostic significance of X ray cross-complementing group 1 T-77C polymorphism in resected non-small cell lung cancer. Jpn J Clin Oncol 2009; 39: 81-85.
19. Roviello F, Corso G, Pedrazzani C, Marrelli D, De Falco G, Berardi A, Garosi L, Suriano G, Vindigni C, De Stefano A, Leoncini L, Seruca R, Pinto E. Hereditary diffuse gastric cancer and E-cadherin: description of the first germline mutation in an Italian family. Eur J Surg Oncol 2007; 33: 448-451.
20. Corso G, Pedrazzani C, Marrelli D, Pinto E, Roviello F. Familial gastric cancer and Li Fraumeni syndrome. Eur J Cancer Care 2009; in press.
21. Lindblad M, Rodríguez LA, Lagergren J. Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control study. Cancer Causes Control 2005; 16: 285-294.
22. Laurén PA, Nevalainen TJ. Epidemiology of intestinal and diffuse types of gastric carcinoma. A time-trend study in Finland with comparison between studies from high- and low-risk areas. Cancer 1993; 71: 2926-2933.
23. Lagarde SM, ten Kate FJ, Reitsma JB, Busch OR, van Lanschot JJ. Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction. J Clin Oncol 2006; 24: 4347-4355.
24. Pedrazzani C, de Manzoni G, Marrelli D, Roviello F. It is time for a proper staging system for adenocarcinoma of the gastroesophageal junction. J Clin Oncol 2007; 25: 907-908.
25. La Torre G, Chiaradia G, Gianfagna F, De Lauretis A, Boccia S, Mannocci A, Ricciardi W. Smoking status and gastric cancer risk: an updated meta-analysis of case-control studies published in the past ten years. Tumori 2009; 95: 13-22.
26. Palli D, Russo A, Ottini L, Masala G, Saieva C, Amorosi A, Cama A, D'Amico C, Falchetti M, Palmirotta R, Decarli A, Mariani Costantini R, Fraumeni JF Jr. Red meat, family history, and increased risk of gastric cancer with microsatellite instability. Cancer Res 2001; 61: 5415-5419.
27. Brenner H, Bode G, Boeing H. Helicobacter pylori infection among offspring of patients with stomach cancer. Gastroenterology 2000; 118: 31-35.